
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+11
Breathe Life Sciences (BXN:ASX) is an Australian multi-national life sciences company focused on research, development, manufacture, and wholesale of novel pharmaceuticals, medicinal cannabis, psilocybin, consumer health and lifestyle products. In 2023 BLS was acquired by Bioxyne (BXN:ASX). The merged group has head offices in Sydney, London, Prague, and Nagoya. The Company operates in Australia, the United Kingdom, Germany, France, Czechia, Japan, and the United States. https://bioxyne.com
Pharmaceutical gmp ,white label manufacture,cbd,nootropics,health supplements,skin care,research & development,clinical trials,medical cannabis,psilocybin,telemedicine,chain of custody,import,export,manufacture,and medicine technology
Breathe life sciences (bxn:asx) operates in the Biotechnology industry.
Breathe life sciences (bxn:asx)'s revenue is 11m - 100m
Breathe life sciences (bxn:asx) has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.